Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4963119 | 6026242 | I | 4963119-2 | 20060317 | 20060331 | EXP | 2006-00650 | MILLENIUM PHARMACEUTICALS INC. | N | 20060327 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4963119 | 1007131905 | PS | VELCADE | 1 | D | D | 21602 | ||||
| 4963119 | 1007173359 | SS | DOXORUBICIN (DOXORUBICIN) | 2 | INTRAVENOUS | 30.00 MG/M2, INTRAVENOUS | U | U |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4963119 | 1007131905 | NON-HODGKIN'S LYMPHOMA |
| 4963119 | 1007173359 | NON-HODGKIN'S LYMPHOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4963119 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 4963119 | DISEASE PROGRESSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4963119 | HP |
| 4963119 | LIT |
| 4963119 | SDY |
Therapies reported
| no results found |